ondasdechoque.org
PT-BR

Skin graft donor sites · Randomized trial · 2010

Does shockwave help the skin heal faster where a graft was taken?

In this trial, one shockwave treatment during surgery helped the area where skin was taken for a graft heal faster: it was at least 95% covered with new skin in about 14 days, compared with about 17 days with standard dressings alone.

Helped skin heal faster than dressings alone
adults having a skin graft after burns or injuries
28
shockwave treatment, during the operation
1
days for all donor sites to heal
11–20

Good to know: Pain and scarring were not measured.

Ottomann C, Hartmann B, Tyler J, et al. J Am Coll Surg, 2010 · Read the paper ↗

How this study worked

Shockwave + dressings13 peopleDressings alone15 people
People were assigned to the groups by lot. Each dot is one person.

The treatment

Shockwave + dressings

Shockwave, 1 session

ShockwavesThe paper doesn’t say whether radial or focused
Sessions
1
Pulses
100 per area · each cm² of donor site
Strength
0.1mJ/mm²
Numbing
Not mentioned · given during the operation
Device
OW 180 C DermaGold
Everyone also got
Silicone mesh dressing (Mepitel) and antiseptic gel, changed daily

Compared with: The same daily dressings without shockwave

Settings are what each study used, not a prescription.

Who took part

28 adults who needed a thin skin graft after burns or injuries: 13 had shockwave and 15 standard care.

Shockwave + dressings13 people
Dressings alone15 people

Side effects

No infection, bleeding, swelling or skin reactions were seen at the donor site in either group.

All the numbers and the full appraisal
FROM THE FULL PAPER

The results, in numbers.

28 adults requiring split-thickness grafting for burns or trauma; 13 ESWT and 15 standard care, all analyzed.

Shockwave treatment13randomized

Participant counts; outcome-specific denominators remain in each panel.

Control15randomized

Participant counts; outcome-specific denominators remain in each panel.

Time to ≥95% epithelialization1 reported outcome
01
Daily until healing

Time to ≥95% epithelialization

Time to ≥95% epithelialization days

means
GroupnBaselineFollow-up
Shockwave treatment13—13.9 (SD 2)
Control15—16.7 (SD 2)

SD: standard deviation. CI: confidence interval. IQR: interquartile range. —: not extracted.

REPORTED COMPARISON TESTp = 0.0001

Between reported groups

Analysis of variance comparing mean time to epithelialization between the two groups

Primary outcome favored ESWT; trial stopped early.

Analysis details and source

Primary outcome favored ESWT; trial stopped early.

How treatment was delivered
Reported protocol

OW 180 C DermaGold, 100 impulses/cm², 0.1 mJ/mm², one intraoperative application, average 13 min; sterile gel/plastic interface. Frequency not stated.

HARMS & TOLERABILITY

No clinically apparent donor-site infection, bleeding, swelling or adverse skin reaction in either group; no structured CTCAE assessment.

LIMITS OF THE ANALYSIS

Early stopping can exaggerate benefit; no pain, distress, quality-of-life or cosmetic outcomes measured. Patients and the outcome assessor were blinded; the treating physician knew each patient's allocation. Schaden/Thiele disclosed TRT stock; Schaden board membership. Partial funding came from the Combat Wound Initiative Program and Internationales Zentrum für Stosswellentherapie.

Findings checked against the full source by a separate automated reviewer.

Limitations noted by the reviewers

  • Early stopping can exaggerate benefit; no pain, distress, quality-of-life or cosmetic outcomes measured. Patients and the outcome assessor were blinded; the treating physician knew each patient's allocation. Schaden/Thiele disclosed TRT stock; Schaden board membership. Partial funding came from the Combat Wound Initiative Program and Internationales Zentrum für Stosswellentherapie.
Research review

Source-linked critical reading

Randomized trials

Reading depthMaterial consulted
Technical source record

Full source read: body, methods, results, all tables and figure captions, discussion and disclosures. External supplements not supplied with local PDF.

Review statusAI-assisted draft · independent automated checkThis automated check comes before the editor’s clinical review.
Study design

Randomized trial of 28 adults, 13 receiving shockwave treatment and 15 standard care; recruitment stopped before the planned sample of 54.

Participants and setting

28 adults requiring split-thickness grafting for burns or trauma; 13 ESWT and 15 standard care, all analyzed.

Treatment delivered

Single defocused treatment immediately after skin harvesting, while anesthetized.

What was compared

Mepitel silicone mesh and polyhexanide/octenidine gel, changed daily in both groups.

Outcomes and timing

The extracted panels retain the original outcome units and assessment times. Time to ≥95% epithelialization was 13.9±2.0 versus 16.7±2.0 days (p=.0001); all donor sites healed within 11–20 days. Study stopped at planned interim analysis after 28 rather than 54 participants.

Results in context

Time to ≥95% epithelialization was 13.9±2.0 versus 16.7±2.0 days (p=.0001); all donor sites healed within 11–20 days. Study stopped at planned interim analysis after 28 rather than 54 participants.

Harms and tolerability

No clinically apparent donor-site infection, bleeding, swelling or adverse skin reaction in either group; no structured CTCAE assessment.

Limits and disclosures

Early stopping can exaggerate benefit; no pain, distress, quality-of-life or cosmetic outcomes measured. Patients and the outcome assessor were blinded; the treating physician knew each patient's allocation. Schaden/Thiele disclosed TRT stock; Schaden board membership. Partial funding came from the Combat Wound Initiative Program and Internationales Zentrum für Stosswellentherapie.

Clinical applicability

Result is specific to donor sites receiving this dressing regimen; it does not establish superior cosmetic healing or less pain.

What a next study should resolve

An adequately powered donor-site trial should avoid efficacy-driven early stopping, use blinded closure assessment, and measure pain, scar quality and structured adverse events.

THE ORIGINAL SOURCE

Read the original article.

Prospective Randomized Trial of Accelerated Re-epithelization of Skin Graft Donor Sites Using Extracorporeal Shock Wave Therapy

Ottomann C, Hartmann B, Tyler J, Maier H, Thiele R, Schaden W, Stojadinovic A. · J Am Coll Surg · 2010

Open the publication record or available full-text files.

Checked against the full paper · Clinical review: Dr. Marcus Yu Bin Pai, · How we review →